Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder

被引：356

作者：

Fukagawa, Masafumi ^{[1
]}

Yokoyama, Keitaro ^{[1
]}

Koiwa, Fumihiko ^{[1
]}

Taniguchi, Masatomo ^{[1
]}

Shoji, Tetsuo ^{[1
]}

Kazama, Junichiro James ^{[1
]}

Komaba, Hirotaka ^{[1
]}

Ando, Ryoichi ^{[1
]}

Kakuta, Takatoshi ^{[1
]}

Fujii, Hideki ^{[1
]}

Nakayama, Msasaaki ^{[1
]}

Shibagaki, Yugo ^{[1
]}

Fukumoto, Seiji ^{[2
]}

Fujii, Naohiko ^{[1
]}

Hattori, Motoshi ^{[1
]}

Ashida, Akira ^{[1
]}

Iseki, Kunitoshi ^{[1
]}

Shigematsu, Takashi ^{[1
]}

Tsukamoto, Yusuke ^{[1
]}

Tsubakihara, Yoshiharu ^{[1
]}

Tomo, Tadashi ^{[1
]}

Hirakata, Hideki ^{[1
]}

Akizawa, Tadao ^{[1
]}

机构：

[1] Japanese Soc Dialysis Therapy, Tokyo, Japan

[2] Japanese Soc Nephrol, Tokyo, Japan

来源：

THERAPEUTIC APHERESIS AND DIALYSIS | 2013年 / 17卷 / 03期

关键词：

Chronic kidney disease-Mineral and Bone Disorders; Clinical practice guideline; Parathyroid hormone; Serum Calcium; Serum phosphorus; Vascular calcification; CHRONIC-RENAL-FAILURE; CORONARY-ARTERY CALCIFICATION; GROWTH-FACTOR; 23; ACTIVE VITAMIN-D; AMBULATORY PERITONEAL-DIALYSIS; PARATHYROID-HORMONE LEVELS; ETHANOL INJECTION THERAPY; BETA(2)-MICROGLOBULIN ADSORPTION COLUMN; CHRONIC-HEMODIALYSIS PATIENTS; SERUM ALKALINE-PHOSPHATASE;

D O I：

10.1111/1744-9987.12058

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：247 / 288

页数：42

共 50 条

[41] Potential for Biomarkers of Chronic Kidney Disease-Mineral Bone Disorder to Improve Patient Care
Alderson, H. V.
Ritchie, J. P.
Green, D.
Chiu, D.
Kalra, P. A.
NEPHRON CLINICAL PRACTICE, 2013, 124 (3-4): : 141 - 150
[42] Uremic Cardiomyopathy: A New Piece in the Chronic Kidney Disease-Mineral and Bone Disorder Puzzle
de Albuquerque Suassuna, Paulo G.
Sanders-Pinheiro, Helady
de Paula, Rogerio B.
FRONTIERS IN MEDICINE, 2018, 5
[43] Chronic Kidney Disease-Mineral Bone Disease Biomarkers in Kidney Transplant Patients
Hasparyk, Ursula Gramiscelli
Borges Vigil, Flavia Maria
Bartolomei, Victoria Soares
Nunes, Vitor Moreira
Simoes e Silva, Ana Cristina
CURRENT MEDICINAL CHEMISTRY, 2022, 29 (31) : 5230 - 5253
[44] Correlation between soluble klotho and chronic kidney disease-mineral and bone disorder in chronic kidney disease: a meta-analysis
Fan, Zhongyu
Wei, Xuejiao
Zhu, Xiaoyu
Yang, Kun
Tian, Ling
Du, Yujun
Yang, Liming
SCIENTIFIC REPORTS, 2024, 14 (01)
[45] Pediatric Mineral and Bone Disorder of Chronic Kidney Disease and Cardiovascular Disease
Kusumi, Kirsten
Kremsdorf, Robin
Kakajiwala, Aadil
Mahan, John D.
ADVANCES IN CHRONIC KIDNEY DISEASE, 2022, 29 (03) : 275 - 282
[46] Role of nutritional vitamin D in chronic kidney disease-mineral and bone disorder: A narrative review
Shen, Yingjing
MEDICINE, 2023, 102 (14) : E33477
[47] The WNT/β-catenin system in chronic kidney disease-mineral bone disorder syndrome
Zhang, Lingbo
Adu, Isaac Kumi
Zhang, Haifeng
Wang, Jiancheng
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (10) : 2527 - 2538
[48] CHRONIC KIDNEY DISEASE-MINERAL BONE DISORDER IN THE ELDERLY PERITONEAL DIALYSIS PATIENT
Heaf, James Goya
PERITONEAL DIALYSIS INTERNATIONAL, 2015, 35 (06): : 640 - 644
[49] Sclerostin in chronic kidney disease-mineral bone disorder think first before you block it!
Brandenburg, Vincent M.
Verhulst, Anja
Babler, Anne
D'Haese, Patrick C.
Evenepoel, Pieter
Kaesler, Nadine
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (03) : 408 - 414
[50] Interleukin-1 inhibition, chronic kidney disease-mineral and bone disorder, and physical function
Nowak, Kristen L.
Hung, Adriana
Ikizler, Talat Alp
Farmer-Bailey, Heather
Salas-Cruz, Natjalie
Sarkar, Sudipa
Hoofnagle, Andrew
You, Zhiying
Chonchol, Michel
CLINICAL NEPHROLOGY, 2017, 88 (03) : 132 - 139

← 1 2 3 4 5 →